JP2009515817A5 - - Google Patents

Download PDF

Info

Publication number
JP2009515817A5
JP2009515817A5 JP2008532404A JP2008532404A JP2009515817A5 JP 2009515817 A5 JP2009515817 A5 JP 2009515817A5 JP 2008532404 A JP2008532404 A JP 2008532404A JP 2008532404 A JP2008532404 A JP 2008532404A JP 2009515817 A5 JP2009515817 A5 JP 2009515817A5
Authority
JP
Japan
Prior art keywords
formula
group
compound
solvent
subscript
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008532404A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009515817A (ja
Filing date
Publication date
Priority claimed from US11/525,200 external-priority patent/US7714131B2/en
Application filed filed Critical
Publication of JP2009515817A publication Critical patent/JP2009515817A/ja
Publication of JP2009515817A5 publication Critical patent/JP2009515817A5/ja
Withdrawn legal-status Critical Current

Links

JP2008532404A 2005-09-23 2006-09-21 （−）−ハロフェナートおよびその中間体の立体選択的調製のための方法 Withdrawn JP2009515817A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72030005P 2005-09-23 2005-09-23
US11/525,200 US7714131B2 (en) 2005-09-23 2006-09-20 Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
PCT/US2006/036928 WO2007038243A1 (en) 2005-09-23 2006-09-21 Process for the stereoselective preparation of (-)-halofenate and intermediates thereof

Publications (2)

Publication Number Publication Date
JP2009515817A JP2009515817A (ja) 2009-04-16
JP2009515817A5 true JP2009515817A5 (enExample) 2009-11-12

Family

ID=37894903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008532404A Withdrawn JP2009515817A (ja) 2005-09-23 2006-09-21 （−）−ハロフェナートおよびその中間体の立体選択的調製のための方法

Country Status (17)

Country Link
US (1) US7714131B2 (enExample)
EP (1) EP1940387B1 (enExample)
JP (1) JP2009515817A (enExample)
KR (1) KR101309605B1 (enExample)
AU (1) AU2006294950A1 (enExample)
BR (1) BRPI0616188A2 (enExample)
CA (1) CA2623350C (enExample)
DK (1) DK1940387T3 (enExample)
EA (1) EA015673B1 (enExample)
ES (1) ES2394973T3 (enExample)
HR (1) HRP20130001T1 (enExample)
IL (1) IL190325A (enExample)
PL (1) PL1940387T3 (enExample)
PT (1) PT1940387E (enExample)
RS (1) RS52608B (enExample)
SI (1) SI1940387T1 (enExample)
WO (1) WO2007038243A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009121940A1 (en) * 2008-04-03 2009-10-08 Janssen Pharmaceutica Nv Process for the preparation of (-)-(4-chloro-phenyl)-(3-trifluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl ester
US8383833B2 (en) * 2008-06-03 2013-02-26 Kaneka Corporation Method for producing optically active amino acid derivative
US9023856B2 (en) 2011-11-04 2015-05-05 Cymabay Therapeutics, Inc. Methods for treating hyperuricemia in patients with gout using halofenate or halogenic acid and a second urate-lowering agent
US9060987B2 (en) 2011-11-04 2015-06-23 Cymabay Therapeutics, Inc. Methods for treating gout flares
US20210355065A1 (en) 2020-05-18 2021-11-18 Cymabay Therapeutics, Inc. CB-0406 tromethamine salt
WO2021236395A1 (en) 2020-05-18 2021-11-25 Cymabay Therapeutics, Inc. Cb-0406 choline salt

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444299A (en) * 1964-02-07 1969-05-13 American Cyanamid Co Methods for the control and prevention of helminths with phenylbenzothiazolium compounds
GB1097053A (en) * 1964-03-16 1967-12-29 Dow Chemical Co Substituted benzothiazolium compounds and complexes thereof for use in animal husbandry
US3378582A (en) * 1964-03-20 1968-04-16 Merck & Co Inc (alpha-phenoxy)-and (alpha-phenylthio)-omegaphenyl-alkanoic acids
US3517051A (en) * 1964-03-20 1970-06-23 Merck & Co Inc Phenoxy substituted phenylacetic acids
US3517050A (en) * 1966-10-03 1970-06-23 Merck & Co Inc Ester and amide derivative of (3-trifluoromethylphenoxy) (4 - halophenyl)acetic acid
NL6712585A (enExample) 1966-10-03 1968-04-04
US3558778A (en) * 1966-10-27 1971-01-26 Dow Chemical Co Methods and compositions for use in animal husbandry
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
BE754245A (fr) * 1969-08-01 1970-12-31 Sumitomo Chemical Co Derives d'acides phenoxy carboxyliques
DK133742B (da) 1970-10-30 1976-07-12 Merck & Co Inc Fremgangsmåde til fremstilling af 2-acetamidoethyl-(3-trifluormethylphenoxy)-(4-chlorphenyl)-acetat.
US3860628A (en) * 1972-07-13 1975-01-14 Merck & Co Inc Cyanomethyl(3-trifluoromethylphenoxy)(4-chlorophenyl)acetate
US3953490A (en) * 1972-07-13 1976-04-27 Merck & Co., Inc. Preparation of (3-trifluoromethylphenoxy)(4-chlorophenyl)acetonitrile
US3923855A (en) * 1972-07-13 1975-12-02 Merck & Co Inc 2-sulfonyloxyethyl 3-trifluoromethylphenoxy-4{40 -chlorophenyl acetate
NL7309571A (enExample) 1972-07-28 1974-01-30
US4110351A (en) * 1973-04-02 1978-08-29 Richardson-Merrell Inc. Hypolipidemic agents RO- or RS- substituted furoic acids, esters and salts
US3876791A (en) * 1973-11-30 1975-04-08 Uniroyal Inc Control of acarids using certain benzothiazoles or benzothiazolines
US4001268A (en) * 1974-08-07 1977-01-04 The United States Of America As Represented By The Secretary Of The Air Force Substituted phenyl-benzimidazo compounds
IL48707A0 (en) * 1974-12-30 1976-02-29 Synthelabo Novel phenylacetic acid derivatives,their preparation and pharmaceutical compositions containing them
JPS6039072B2 (ja) 1976-07-28 1985-09-04 藤沢薬品工業株式会社 Ｎ−置換フエニルアミノ脂肪酸誘導体
JPS5371071A (en) 1976-12-08 1978-06-24 Teijin Ltd Alpha-phenoxyacetic acid derivs.
US4250191A (en) * 1978-11-30 1981-02-10 Edwards K David Preventing renal failure
US4214095A (en) * 1979-01-25 1980-07-22 Siegfried Aktiengesellschaft Chlorobenzyl phenoxy alkoxylates
DK187880A (da) * 1979-05-04 1980-11-05 Continental Pharma Fremgangsmaade til fremstilling af fenyl tylaminderivater
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds
US4508882A (en) * 1981-08-24 1985-04-02 Asahi Glass Company Ltd. Benzotriazole compound and homopolymer or copolymers thereof
EP0077938A3 (en) 1981-10-23 1983-08-24 Mitsubishi Kasei Corporation N-(3-substituted aminophenyl) tetrahydrophthalimides and herbicidal composition
DE3236730A1 (de) 1982-10-04 1984-04-05 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von benzoxazolyl- und benzthiazolyloxyphenoxypropionsaeurederivaten
US4528311A (en) * 1983-07-11 1985-07-09 Iolab Corporation Ultraviolet absorbing polymers comprising 2-hydroxy-5-acrylyloxyphenyl-2H-benzotriazoles
JPS60109578A (ja) 1983-11-17 1985-06-15 Mitsubishi Chem Ind Ltd ３−（置換フエニル）−５−置換−１，３，４−オキサゾリン−２−オン類およびこれを有効成分とする除草剤
DE3525284A1 (de) * 1985-07-16 1987-01-29 Boehringer Mannheim Gmbh Neue carbonsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung sowie arzneimittel, die diese verbindungen enthalten
US4714762A (en) * 1986-10-31 1987-12-22 Warner-Lambert Company Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidazo[4,5-b]pyridin-2-yl-phenoxy-alkanoic acids and salts and esters thereof
US4786731A (en) * 1987-08-05 1988-11-22 The Dow Chemical Company Resolution of enantiomers of 2-(phenyl or phenoxy/propionic acids using optically active alkanolamines
JPH0670025B2 (ja) * 1987-08-07 1994-09-07 鐘紡株式会社 ベンゾチアゾ−ル誘導体および該化合物を有効成分とする抗リウマチ剤
GB8720365D0 (en) * 1987-08-28 1987-10-07 Sandoz Ltd Organic compounds
US4863802A (en) * 1987-12-31 1989-09-05 General Electric Company UV-stabilized coatings
JPH01305069A (ja) * 1988-05-31 1989-12-08 Shionogi & Co Ltd ベンゾトリアゾール誘導体およびそれを含有する発螢光試薬
CA2034309C (en) * 1990-01-22 1997-04-01 Takashi Iwaki Mesomorphic compound, liquid crystal composition containing same, liquid crystal device using same and display apparatus
US5278314A (en) * 1991-02-12 1994-01-11 Ciba-Geigy Corporation 5-thio-substituted benzotriazole UV-absorbers
DE4111026A1 (de) 1991-04-05 1992-10-08 Boehringer Mannheim Gmbh Optisch aktive carbonsaeuren sowie diese enthaltende arzneimittel
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
ATE149481T1 (de) * 1992-03-09 1997-03-15 Hoechst Ag Vereinfachende verfahren zur herstellung von vinylglycin (2-aminobut-3-ensäure) und passende auflösung von einem derivat
DE4303676A1 (de) * 1993-02-09 1994-08-11 Bayer Ag 1-Aryltriazolin(thi)one
US5874431A (en) * 1993-08-28 1999-02-23 Cancer Research Campaign Technology Limited Benzazole compounds
US5496826A (en) * 1994-09-02 1996-03-05 Bristol-Myers Squibb Company Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides
US5455152A (en) * 1994-09-27 1995-10-03 Eastman Kodak Company Benzotriazole based UV absorbing monomers and photographic elements containing polymers formed from them
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
ATE202783T1 (de) * 1994-12-28 2001-07-15 Rhodia Chimie Sa Optisch aktive diphosphine und herstellungsverfahren durch auftrennung der racematmischung
GB9503946D0 (en) * 1995-02-28 1995-04-19 Cancer Res Campaign Tech Benzazole compounds
US5500332A (en) * 1995-04-26 1996-03-19 Eastman Kodak Company Benzotriazole based UV absorbers and photographic elements containing them
US5708186A (en) * 1995-12-12 1998-01-13 Merck & Co Inc Stereoselective process
US6242464B1 (en) * 1996-01-22 2001-06-05 Chiroscience Limited Single isomer methylphenidate and resolution process
US5859051A (en) * 1996-02-02 1999-01-12 Merck & Co., Inc. Antidiabetic agents
US5766834A (en) * 1996-05-17 1998-06-16 Eastman Kodak Company Photographic element containing ultraviolet absorbing polymer
US5716987A (en) * 1996-06-21 1998-02-10 Bristol-Myers Squibb Company Prophylactic and therapeutic treatment of skin sensitization and irritation
JP2000516611A (ja) * 1996-08-14 2000-12-12 ワーナー―ランバート・コンパニー Ｍｃｐ―１アンタゴニストとしての２―フェニルベンズイミダゾール誘導体
US6201000B1 (en) * 1996-11-22 2001-03-13 Ciba Specialty Chemicals Corporation Use of selected benzotriazole derivatives for protecting human and animal skin and hair from the harmful effects of UV radiation
US5942532A (en) 1997-09-05 1999-08-24 Ortho Pharmaceutical Corporation 2-substituted phenyl-benzimidazole antibacterial agents
DK0974589T3 (da) 1997-11-07 2004-05-03 Taiho Pharmaceutical Co Ltd Benzimidazolderivater og farmaceutiske acceptable salte deraf
US6506747B1 (en) * 1998-06-05 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
US6013659A (en) * 1998-09-04 2000-01-11 University Of Pittsburgh Methods of reducing tumor colony number using novel benzothiazole compounds
DE19844876A1 (de) * 1998-09-30 2000-04-06 Basf Ag Verfahren zur Racematspaltung von Arylalkylcarbonsäureestern
IN189741B (enExample) * 1998-11-09 2003-04-19 Council Scient Ind Res
CZ20012006A3 (cs) 1998-12-18 2002-03-13 Axys Pharmaceuticals, Inc. Sloučenina a farmaceutický prostředek
US6262118B1 (en) * 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US7576131B2 (en) * 1999-06-04 2009-08-18 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US6624194B1 (en) * 1999-06-04 2003-09-23 Metabolex, Inc. Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
WO2001047883A1 (fr) 1999-12-27 2001-07-05 Japan Tobacco Inc. Composes a cycles accoles et leur utilisation comme medicaments
US20040204472A1 (en) * 2003-03-04 2004-10-14 Pharmacia Corporation Treatment and prevention of obesity with COX-2 inhibitors alone or in combination with weight-loss agents
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
EP1635809A4 (en) 2003-06-20 2006-09-27 Metabolex Inc RESOLUTION OF ALPHA (PHENOXY) PHENYLACETIC ACID DERIVATIVES

Similar Documents

Publication Publication Date Title
HRP20140668T1 (hr) Postupak proizvodnje prasugrel hidroklorida visoke äśistoä†e
JP2012504153A5 (enExample)
JP2010540426A5 (enExample)
JP2009515817A5 (enExample)
JP2005527623A5 (enExample)
CN1190406C (zh) 邻烷基化苯甲酸衍生物的制备方法
JP2011528380A5 (enExample)
JP2011098952A (ja) ジエポキシ化合物の製造方法
JP2007091692A (ja) ５−メチル−２−フルフラールの製造方法
AU2014221199A1 (en) Methods for preparing acrylic acid from biobased starting materials
JP2012512943A5 (enExample)
Yusubov et al. m-Iodosylbenzoic acid, a tagged hypervalent iodine reagent for the iodo-functionalization of alkenes and alkynes
HRP20130001T1 (hr) Postupak za stereoselektivno pripremanje (-)-halofenata i njegovih intermedijara
JP2008529986A5 (enExample)
ATE396964T1 (de) Verfahren zur herstellung von phthalsauredichlorid
JP5900182B2 (ja) α，α−ジフルオロ芳香族化合物の製造方法
JP4867201B2 (ja) 光学活性１，１，１−トリフルオロ−２，３−エポキシプロパンの製造方法
CN1269775C (zh) 选择性加氢脱卤方法
JP6809485B2 (ja) 酸ハライド溶液の製造方法、及びモノエステル化合物の製造方法
CN106083805A (zh) 一种溴代碳酸酯的制备方法
EP3604282A1 (en) Method for producing halogen-containing pyrazol carboxylic acid and intermediate thereof
JP2007031437A5 (enExample)
JP2008533169A5 (enExample)
JP2008013519A (ja) 光学活性２−フルオロアルコール誘導体の製造方法
JP4951957B2 (ja) フルフラール類の製造方法